There’s more to enzyme antagonism than inhibition
[Display omitted] A native enzyme's usual assurance in recognizing their physiological substrate(s) at the ground state and on going to the transition state can be undermined by interactions with selected small molecule antagonists, leading to the generation of abnormal products. We classify th...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2023-03, Vol.82, p.117231-117231, Article 117231 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 117231 |
---|---|
container_issue | |
container_start_page | 117231 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 82 |
creator | Callahan, Brian P. Xu, Zihan |
description | [Display omitted]
A native enzyme's usual assurance in recognizing their physiological substrate(s) at the ground state and on going to the transition state can be undermined by interactions with selected small molecule antagonists, leading to the generation of abnormal products. We classify this mode of enzyme antagonism resulting in the gain-of-nonnative-function as paracatalytic induction. Enzymes bound by paracatalytic inducers exhibit new or enhanced activity toward transformations that appear aberrant or erroneous. The enzyme/ paracatalytic inducer complex may take up native substrate but then bring about a transformation that is chemically distinct from the normal reaction. Alternatively, the enzyme / paracatalytic inducer complex may exhibit abnormal ground state selectivity, preferentially interacting with and transforming a molecule outside the physiological substrate scope. Paracatalytic inducers can be cytotoxic, while in other cases they divert enzyme activity toward transformations that appear adaptive and even therapeutically useful. In this perspective, we highlight two noteworthy examples from recent literature. |
doi_str_mv | 10.1016/j.bmc.2023.117231 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10228466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089623000792</els_id><sourcerecordid>2786102073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3191-990f1cdb31edf23e67133b394746235a270b5b0d058b46268bfa993382c4fc893</originalsourceid><addsrcrecordid>eNp9kM9OHDEMh6OqqCy0D8ClmmMvs8TxbGYiDlWF-Cch9QLnKMl42Kx2EprMIsGpr9HX40kIWkBw6cmS_fln62PsAPgcOMjD1dyObi64wDlAKxA-sRk0sqkRFXxmM65kV_NOyV22l_OKcy4aBV_YLspO4UK0M4ZXS0r0-PdfrsaYqJpiReHhfqTKhMncxODzWE1LEyoflt76ycfwle0MZp3p20vdZ9enJ1fH5_Xl77OL41-XtUNQUCvFB3C9RaB-EEiyBUSLqmkbKXBhRMvtwvKeLzpbOrKzg1EKsROuGVx5cJ_93ObebuxIvaMwJbPWt8mPJt3raLz-OAl-qW_inQYuRNdIWRJ-vCSk-GdDedKjz47WaxMobrIWbScLzFssKGxRl2LOiYa3O8D1s2290sW2fratt7bLzvf3D75tvOotwNEWoKLpzlPS2XkKjnqfyE26j_4_8U-oKI_P</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786102073</pqid></control><display><type>article</type><title>There’s more to enzyme antagonism than inhibition</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Callahan, Brian P. ; Xu, Zihan</creator><creatorcontrib>Callahan, Brian P. ; Xu, Zihan</creatorcontrib><description>[Display omitted]
A native enzyme's usual assurance in recognizing their physiological substrate(s) at the ground state and on going to the transition state can be undermined by interactions with selected small molecule antagonists, leading to the generation of abnormal products. We classify this mode of enzyme antagonism resulting in the gain-of-nonnative-function as paracatalytic induction. Enzymes bound by paracatalytic inducers exhibit new or enhanced activity toward transformations that appear aberrant or erroneous. The enzyme/ paracatalytic inducer complex may take up native substrate but then bring about a transformation that is chemically distinct from the normal reaction. Alternatively, the enzyme / paracatalytic inducer complex may exhibit abnormal ground state selectivity, preferentially interacting with and transforming a molecule outside the physiological substrate scope. Paracatalytic inducers can be cytotoxic, while in other cases they divert enzyme activity toward transformations that appear adaptive and even therapeutically useful. In this perspective, we highlight two noteworthy examples from recent literature.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2023.117231</identifier><identifier>PMID: 36893527</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antagonism ; DNA repair ; Enzyme ; Enzyme Inhibitors - pharmacology ; HTS ; Kinase ; Nonnative activity ; Paracatalysis ; Protein Binding</subject><ispartof>Bioorganic & medicinal chemistry, 2023-03, Vol.82, p.117231-117231, Article 117231</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3191-990f1cdb31edf23e67133b394746235a270b5b0d058b46268bfa993382c4fc893</cites><orcidid>0000-0003-4826-0162</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2023.117231$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,778,782,883,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36893527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Callahan, Brian P.</creatorcontrib><creatorcontrib>Xu, Zihan</creatorcontrib><title>There’s more to enzyme antagonism than inhibition</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted]
A native enzyme's usual assurance in recognizing their physiological substrate(s) at the ground state and on going to the transition state can be undermined by interactions with selected small molecule antagonists, leading to the generation of abnormal products. We classify this mode of enzyme antagonism resulting in the gain-of-nonnative-function as paracatalytic induction. Enzymes bound by paracatalytic inducers exhibit new or enhanced activity toward transformations that appear aberrant or erroneous. The enzyme/ paracatalytic inducer complex may take up native substrate but then bring about a transformation that is chemically distinct from the normal reaction. Alternatively, the enzyme / paracatalytic inducer complex may exhibit abnormal ground state selectivity, preferentially interacting with and transforming a molecule outside the physiological substrate scope. Paracatalytic inducers can be cytotoxic, while in other cases they divert enzyme activity toward transformations that appear adaptive and even therapeutically useful. In this perspective, we highlight two noteworthy examples from recent literature.</description><subject>Antagonism</subject><subject>DNA repair</subject><subject>Enzyme</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>HTS</subject><subject>Kinase</subject><subject>Nonnative activity</subject><subject>Paracatalysis</subject><subject>Protein Binding</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9OHDEMh6OqqCy0D8ClmmMvs8TxbGYiDlWF-Cch9QLnKMl42Kx2EprMIsGpr9HX40kIWkBw6cmS_fln62PsAPgcOMjD1dyObi64wDlAKxA-sRk0sqkRFXxmM65kV_NOyV22l_OKcy4aBV_YLspO4UK0M4ZXS0r0-PdfrsaYqJpiReHhfqTKhMncxODzWE1LEyoflt76ycfwle0MZp3p20vdZ9enJ1fH5_Xl77OL41-XtUNQUCvFB3C9RaB-EEiyBUSLqmkbKXBhRMvtwvKeLzpbOrKzg1EKsROuGVx5cJ_93ObebuxIvaMwJbPWt8mPJt3raLz-OAl-qW_inQYuRNdIWRJ-vCSk-GdDedKjz47WaxMobrIWbScLzFssKGxRl2LOiYa3O8D1s2290sW2fratt7bLzvf3D75tvOotwNEWoKLpzlPS2XkKjnqfyE26j_4_8U-oKI_P</recordid><startdate>20230315</startdate><enddate>20230315</enddate><creator>Callahan, Brian P.</creator><creator>Xu, Zihan</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4826-0162</orcidid></search><sort><creationdate>20230315</creationdate><title>There’s more to enzyme antagonism than inhibition</title><author>Callahan, Brian P. ; Xu, Zihan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3191-990f1cdb31edf23e67133b394746235a270b5b0d058b46268bfa993382c4fc893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antagonism</topic><topic>DNA repair</topic><topic>Enzyme</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>HTS</topic><topic>Kinase</topic><topic>Nonnative activity</topic><topic>Paracatalysis</topic><topic>Protein Binding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Callahan, Brian P.</creatorcontrib><creatorcontrib>Xu, Zihan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Callahan, Brian P.</au><au>Xu, Zihan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>There’s more to enzyme antagonism than inhibition</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2023-03-15</date><risdate>2023</risdate><volume>82</volume><spage>117231</spage><epage>117231</epage><pages>117231-117231</pages><artnum>117231</artnum><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted]
A native enzyme's usual assurance in recognizing their physiological substrate(s) at the ground state and on going to the transition state can be undermined by interactions with selected small molecule antagonists, leading to the generation of abnormal products. We classify this mode of enzyme antagonism resulting in the gain-of-nonnative-function as paracatalytic induction. Enzymes bound by paracatalytic inducers exhibit new or enhanced activity toward transformations that appear aberrant or erroneous. The enzyme/ paracatalytic inducer complex may take up native substrate but then bring about a transformation that is chemically distinct from the normal reaction. Alternatively, the enzyme / paracatalytic inducer complex may exhibit abnormal ground state selectivity, preferentially interacting with and transforming a molecule outside the physiological substrate scope. Paracatalytic inducers can be cytotoxic, while in other cases they divert enzyme activity toward transformations that appear adaptive and even therapeutically useful. In this perspective, we highlight two noteworthy examples from recent literature.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36893527</pmid><doi>10.1016/j.bmc.2023.117231</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4826-0162</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2023-03, Vol.82, p.117231-117231, Article 117231 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10228466 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antagonism DNA repair Enzyme Enzyme Inhibitors - pharmacology HTS Kinase Nonnative activity Paracatalysis Protein Binding |
title | There’s more to enzyme antagonism than inhibition |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A45%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=There%E2%80%99s%20more%20to%20enzyme%20antagonism%20than%20inhibition&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Callahan,%20Brian%20P.&rft.date=2023-03-15&rft.volume=82&rft.spage=117231&rft.epage=117231&rft.pages=117231-117231&rft.artnum=117231&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2023.117231&rft_dat=%3Cproquest_pubme%3E2786102073%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2786102073&rft_id=info:pmid/36893527&rft_els_id=S0968089623000792&rfr_iscdi=true |